272 related articles for article (PubMed ID: 12428908)
1. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.
Bungener L; Huckriede A; Wilschut J; Daemen T
Biosci Rep; 2002 Apr; 22(2):323-38. PubMed ID: 12428908
[TBL] [Abstract][Full Text] [Related]
2. Virosomes for antigen and DNA delivery.
Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
[TBL] [Abstract][Full Text] [Related]
3. Virosome-mediated delivery of protein antigens to dendritic cells.
Bungener L; Serre K; Bijl L; Leserman L; Wilschut J; Daemen T; Machy P
Vaccine; 2002 May; 20(17-18):2287-95. PubMed ID: 12009284
[TBL] [Abstract][Full Text] [Related]
4. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
Bungener L; Huckriede A; de Mare A; de Vries-Idema J; Wilschut J; Daemen T
Vaccine; 2005 Jan; 23(10):1232-41. PubMed ID: 15652665
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.
Arkema A; Huckriede A; Schoen P; Wilschut J; Daemen T
Vaccine; 2000 Jan; 18(14):1327-33. PubMed ID: 10618529
[TBL] [Abstract][Full Text] [Related]
6. Liposomal delivery of CTL epitopes to dendritic cells.
Chikh G; Schutze-Redelmeier MP
Biosci Rep; 2002 Apr; 22(2):339-53. PubMed ID: 12428909
[TBL] [Abstract][Full Text] [Related]
7. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.
Mandal M; Lee KD
Biochim Biophys Acta; 2002 Jun; 1563(1-2):7-17. PubMed ID: 12007619
[TBL] [Abstract][Full Text] [Related]
8. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
10. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.
Wijburg OL; van den Dobbelsteen GP; Vadolas J; Sanders A; Strugnell RA; van Rooijen N
Eur J Immunol; 1998 Feb; 28(2):479-87. PubMed ID: 9521056
[TBL] [Abstract][Full Text] [Related]
11. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
12. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
14. Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens.
Bungener L; Idema J; ter Veer W; Huckriede A; Daemen T; Wilschut J
J Liposome Res; 2002; 12(1-2):155-63. PubMed ID: 12604050
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
16. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
[TBL] [Abstract][Full Text] [Related]
17. Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.
Schumacher R; Adamina M; Zurbriggen R; Bolli M; Padovan E; Zajac P; Heberer M; Spagnoli GC
Vaccine; 2004 Jan; 22(5-6):714-23. PubMed ID: 14741164
[TBL] [Abstract][Full Text] [Related]
18. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
19. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
Porgador A; Gilboa E
J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
